This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Asia: Oligonucleotide & Peptide Therapeutics
26-28 Feb, 2025
Westin Miyako KyotoKyoto, Japan
Book Now
Menu
Book Now

Tomomi Sato
Associate Director at Takeda Pharmaceutical Company Limited
Speaker

Agenda Sessions

  • Key Points in Oligonucleotide Formulation Development, AI/ML-Driven LNP Development, and Scale-Up: General Overview and Case Studies

    , 9:15am
    View Session

At this event

Prev
Next
Dr. Dong Shen, MD, PhD
CEO
RNAimmune, Inc.

See Tomomi at TIDES Asia: Oligonucleotide & Peptide Therapeutics

Book Now